ZA906356B - Process for the manufacture of parenteral application formulations - Google Patents

Process for the manufacture of parenteral application formulations

Info

Publication number
ZA906356B
ZA906356B ZA906356A ZA906356A ZA906356B ZA 906356 B ZA906356 B ZA 906356B ZA 906356 A ZA906356 A ZA 906356A ZA 906356 A ZA906356 A ZA 906356A ZA 906356 B ZA906356 B ZA 906356B
Authority
ZA
South Africa
Prior art keywords
manufacture
parenteral application
application formulations
formulations
parenteral
Prior art date
Application number
ZA906356A
Inventor
Alberto Ferro
Ferro Alberto
Pierre-Charles Wyss
Wyss Pierre-Charles
Original Assignee
Hoffman La Roche A G F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffman La Roche A G F filed Critical Hoffman La Roche A G F
Publication of ZA906356B publication Critical patent/ZA906356B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ZA906356A 1989-08-18 1990-08-10 Process for the manufacture of parenteral application formulations ZA906356B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH301589 1989-08-18

Publications (1)

Publication Number Publication Date
ZA906356B true ZA906356B (en) 1991-04-24

Family

ID=4246725

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906356A ZA906356B (en) 1989-08-18 1990-08-10 Process for the manufacture of parenteral application formulations

Country Status (7)

Country Link
EP (1) EP0413246A3 (en)
JP (1) JPH0390019A (en)
AU (1) AU6095090A (en)
CA (1) CA2021441A1 (en)
IE (1) IE902991A1 (en)
NZ (1) NZ234872A (en)
ZA (1) ZA906356B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002257602A (en) * 2001-02-28 2002-09-11 Yazaki Corp Vehicle-mounted meter an dial used for the same
JP4700291B2 (en) * 2003-04-28 2011-06-15 武田薬品工業株式会社 Injectable composition
TWI344847B (en) * 2003-04-28 2011-07-11 Takeda Chemical Industries Ltd Composition for injection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2364414A1 (en) * 1973-01-03 1974-07-11 Compaselect Gmbh ADDITIVE AND PROCESS FOR PREPARING SOLUTIONS FOR INFUSION
DE3538771A1 (en) * 1985-10-31 1987-05-07 Nattermann A & Cie PARENTERAL APPLICABLE FORMS OF AMITRIPTYLINOXIDE
FR2598081B1 (en) * 1986-04-30 1990-02-02 Chauvin Blache Lab PROCESS FOR THE PREPARATION OF AN AQUEOUS PHARMACEUTICAL SOLUTION OF AN ACTIVE INGREDIENT CONSTITUTED BY AN ORGANIC ACID

Also Published As

Publication number Publication date
NZ234872A (en) 1992-08-26
IE902991A1 (en) 1991-02-27
EP0413246A3 (en) 1991-06-05
JPH0390019A (en) 1991-04-16
AU6095090A (en) 1991-02-21
CA2021441A1 (en) 1991-02-19
EP0413246A2 (en) 1991-02-20

Similar Documents

Publication Publication Date Title
HU903415D0 (en) Process for the production of perfluor-polyether-peroxides
ZA915786B (en) Process for the manufacture of biphenylcarbonitriles
EP0428003A3 (en) Process for the preparation of polyetherglycols
EP0425930A3 (en) Process for the preparation of symmetrical diarylacetylenes
ZA915396B (en) Process for the preparation of 1-hydroxymethylpyrazoles
EP0439745A3 (en) Process for the preparation of 2-chloro-5-methyl-pyridine
HU901630D0 (en) Process for the preparation of o-carboxy-pyridyl- and o-carboxy-imidazolinones
HU895262D0 (en) Improved process for the preparation of phenfluramine
HU901603D0 (en) Process for the preparation of fluoro-phenols
IL93596A0 (en) Process for the preparation of n-allylmetatrifluoromethyl-aniline
EP0449778A3 (en) Process for the preparation of hydroxyphenylepropionates
EP0444460A3 (en) Process for the preparation of acrolin
IL97512A0 (en) Process for the preparation of 1-hydroxyalkyl-5-nitro-imidazoles
ZA906356B (en) Process for the manufacture of parenteral application formulations
EP0412361A3 (en) Process for the preparation of 4-methylentetrahydropyran
EP0415189A3 (en) Process for the preparation of aminbenzylalcohol
IL95496A0 (en) Process for the preparation of fluoropyridines
IL98877A0 (en) Process for the preparation of n-alkylsulfonylamino-sulfonylureas
HU9201097D0 (en) Process for the production of tetratiocarbonates
GB2236535B (en) Process for the preparation of nu-substituted nitro-p-phenylenediamines
EP0437820A3 (en) Process for the preparation of glycosyl-anthracyclinones
IL98876A0 (en) Process for the preparation of n-alkylsulfonyl aminosulfonylureas
EP0459242A3 (en) Process for the preparation of phenolethers
EP0440010A3 (en) Process for the manufacture of nitrophenetole
EP0415166A3 (en) Process for the preparation of cyanohydantoines